Work

MA04.03 Osimertinib-induced Epigenetic and Transcriptional Reprogramming Drives a BRD4-POUF-PDGFRB-YAP-EMT Axis of Resistance in NSCLC

Year: 2023

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.136

Authors: A.-V. Hartley, C. Weston, M. Al-Dulaimi, S. Baldacci, W. Feng, M. Booker, M. Tolstorokuv, P. Janne

Institutions: Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388045221

Cites:

Cited by: 1

Related to: 10